Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer

Xiaoshan Wang, Ming Zeng, Vivek Verma et al.|JNCI Journal of the National Cancer Institute|2022

Cited by 267